Skip to main content

NCBiotech News

  • The Biotechnology Center is now accepting fellowship applications for the Industrial Fellowship program. This program provides North Carolina’s Ph.D. scientists with an opportunity to gain industry experience and companies to benefit from new talent and expertise. The program is for recent doctoral graduates and postdoctoral fellows who would like to transition from academia to permanent employment in the state’s life sciences industry.
  • A new biopharmaceutical company has been spawned in Research Triangle Park to commercialize a cancer-fighting technology licensed from its development-stage parent firm. Oncotide Pharmaceuticals was launched by Dale Christensen, Ph.D., vice president of research and business development with Cognosci, Michael Vitek, Ph.D., CEO of Cognosci, and Anil Goyal, Ph.D., an entrepreneur who has been involved in starting several successful life science companies.
  • Teachers, counselors and administrators from all over eastern North Carolina attended the 2011 Biotechnology Education Forum on Wednesday, March 23rd at the Vernon James Research Center in Plymouth. The Biotechnology Center’s Eastern Regional office hosted and sponsored this event.
  • Raleigh medical diagnostics company LipoScience, started with loan help from the North Carolina Biotechnology Center, has named former Blue Cross Blue Shield of North Carolina CEO Robert Greczyn Jr. and Woodrow Myers Jr., M.D., managing director for Myers Ventures LLC, to its board of directors. More
  • The United States ambassador from the Netherlands, Renee Jones-Bos, visited the DSM Pharmaceuticals campus in Greenville this week. Jones-Bos talked with managers of the contract manufacturing facility and with others at DSM’s adjacent Dyneema fiber plant.
  • Barbara Entwisle, Ph.D., Kenan Distinguished Professor of Sociology at the University of North Carolina at Chapel Hill and a member of the NC Biotechnology Center board, has been appointed vice chancellor for research, succeeding Tony Waldrop, who left last summer to become provost and vice president for academic affairs at the University of Central Florida. More
  • Abdul K. Mohammed, Ph.D., chairman of the chemistry department at Winston-Salem State University, has been appointed dean of the College of Science and Technology (CST) at North Carolina Central University.  At the Durham campus, Mohammed oversees the college’s six academic departments: Biology, Chemistry, Physics, Mathematics and Computer Science, Pharmaceutical Sciences, and Environmental, Earth and Geospatial Sciences. 
  • Chapel Hill pharmaceutical company POZEN has sold some South American marketing rights to one of its two marketed products. POZEN agreed to let Cilag GmbH International, a division of Johnson & Johnson, develop and commercialize its migraine drug MT 400 in Brazil, Colombia, Ecuador and Peru. The companies didn't disclose financial terms of the deal.
  • IMPACT, the quarterly magazine covering North Carolina’s biotechnology world, has added another major sponsor. BTEC, officially known as North Carolina State University’s Golden LEAF Biomanufacturing Training and Education Center, has agreed to help fund articles about its programs, beginning with the spring 2011 issue.
  • President Barack Obama told a Charlotte TV reporter he loves the Queen City and admires North Carolina’s winning commitment to biotechnology as an engine of economic vitality. The comments came during an exclusive interview with WSOC-TV Eyewitness News Anchor Natalie Pasquarella, conducted at the White House last Friday.
  • Jason Shih, Ph.D. chairman and co-founder of Morrisville agricultural biotechnology company BioResource International, is the opening speaker in the first plenary session of the Asian Pacific Poultry Conference at the Taipei International Convention Center in Taiwan March 20-23, 2011. More 
  •  If you’re chasing money to help you start or build a new nano business in North Carolina, get your “elevator speech” dusted off for the real deal March 29 in Charlotte. The Center of Innovation for Nanobiotechnolgy (COIN) is hosting its first private pitch and strategy coaching session with a team of seasoned investors as part of the 2011 North Carolina Nanotechnology Commercialization Conference in Charlotte March 29 and 30. 
  • Registration is now open for the 2011 Summer Biotechnology Workshops for Educators. Since 1987, the Summer Workshops have trained more than 1,700 teachers. These teachers have taken the latest biotechnology practices from the workshops back to their classrooms, reaching more than 600,000 students in North Carolina. Each workshop is one-week and features hands-on activities that engage students and improve learning. Registration is $75 and includes:
  • More than 130 attendees visited Forsyth Technical Community College last night to hear Targacept CEO Donald deBethizy give an outstanding talk on Targacept from the “Bench to the Bedside”, as part of the SciTech Lecture Series. The speaking event, presented by Forsyth Tech and the National Center for the Biotechnology Workforce, was in celebration of Forsyth Tech’s 50th anniversary.
  •  Advanced Animal Diagnostics, boosted in 2006 with a $20,000 business development loan from the North Carolina Biotechnology Center, has raised $11 million in B round funding. The 10-year-old North Carolina State University spinout is developing a diagnostic test for mastitis, a type of infection that can reduce cows’ milk production.
  • Joseph Nixon has joined the North Carolina Biotechnology Center as business development director.  Nixon will manage two of the Biotechnology Center’s loan programs for emerging biotechnology companies and supervise the Center’s investments in angel funds and networks.
  • Quintiles Senior Vice President for Corporate Development Vincent Morgus has joined Cornerstone Therapeutics of Cary as executive vice president of finance and chief financial officer. More David Grange, who replaced PPD founder Fred Eshelman as CEO in 2009, is retiring on May 18 when the Wilmington-based contract research giant holds its annual meeting. More 
  • Oxygen Biotherapeutics, a publicly traded development-stage pharmaceutical company that recently moved its corporate headquarters to Morrisville from Durham, has received a grant from the U.S. Army for more than $2 million. The two year funding is to support further study of OxyBio’s lead prescription product candidate, Oxycyte, as a way to transport damage-limiting oxygen to treat traumatic brain injury. OxyBio has also begun Phase II human clinical trials in Europe and Israel.
  • Bayer CropScience is preparing to add a $20 million greenhouse to its North American headquarters in Research Triangle Park. The 60,000-square-foot building addition, which includes about 30,000 square feet of greenhouse space, will accommodate 25 staff members supporting the agricultural biotechnology company’s research and development expansion within the United States.
  • Durham-based BioCryst Pharmaceuticals has received another $55 million federal boost to support the company’s development of a drug for seriously ill people hospitalized with flu.


Subscribe to News & Events